Carestream received U.S. Food and Drug Administration (FDA) clearance for its new lesion management module, which is a native oncology follow-up application that can be added for its Vue PACS. Carestream will demonstrate its lesion management tools on a Vue PACS workstation at the upcoming Radiological Society of North America (RSNA) tradeshow.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now